GTC
AGIO icon

Ghost Tree Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Ghost Tree Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-175,000
Closed -$6.13M – 45
2020
Q3 		$6.13M Buy
175,000
+60,000
+52% +$2.63M 1.77% 20
2020
Q2 		$6.15M Buy
+115,000
New +$5.32M 1.62% 25
2017
Q2 		– Sell
-125,000
Closed -$7.3M – 68
2017
Q1 		$7.3M Sell
125,000
-15,000
-11% -$719K 1.36% 32
2016
Q4 		$5.84M Buy
+140,000
New +$7.35M 1.41% 32
2016
Q2 		– Sell
-140,000
Closed -$5.68M – 68
2016
Q1 		$5.68M Buy
+140,000
New +$5.99M 3.22% 10
2014
Q4 		– Sell
-20,000
Closed -$1.23M – 62
2014
Q3 		$1.23M Buy
+20,000
New +$862K 0.67% 53

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ghost Tree Capital's AGIO Position: Q4 2020 in Review

Ghost Tree Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 175,000 shares — an estimated $6.13M sold.

Ghost Tree Capital first reported a position in AGIO in Q3 2014 and held it in 6 quarters. The position peaked at $7.3M in Q1 2017. 200 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Ghost Tree Capital reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Ghost Tree Capital sold 175,000 Agios Pharmaceuticals shares in Q4 2020, an estimated $6.13M.
  • Ghost Tree Capital first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 6 quarters.
  • Ghost Tree Capital's Agios Pharmaceuticals position peaked at $7.3M in Q1 2017.
  • 200 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Ghost Tree Capital's 13F filing for Q4 2020, filed 16 Feb 2021.